Hollencrest Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $493K | Hold |
1,215
| – | – | 0.02% | 185 |
|
|
2025
Q1 | $605K | Sell |
1,215
-13
| -1% | -$6.47K | 0.03% | 171 |
|
|
2024
Q4 | $639K | Buy |
1,228
+200
| +19% | +$104K | 0.03% | 169 |
|
|
2024
Q3 | $636K | Buy |
1,028
+13
| +1% | +$8.04K | 0.03% | 187 |
|
|
2024
Q2 | $561K | Hold |
1,015
| – | – | 0.02% | 183 |
|
|
2024
Q1 | $590K | Sell |
1,015
-1,569
| -61% | -$912K | 0.03% | 185 |
|
|
2023
Q4 | $1.37M | Sell |
2,584
-1,970
| -43% | -$1.05M | 0.13% | 97 |
|
|
2023
Q3 | $2.31M | Sell |
4,554
-2
| -0% | -$1.01K | 0.26% | 60 |
|
|
2023
Q2 | $2.38M | Hold |
4,556
| – | – | 0.25% | 62 |
|
|
2023
Q1 | $2.63M | Buy |
4,556
+1,565
| +52% | +$902K | 0.28% | 57 |
|
|
2022
Q4 | $1.65M | Buy |
2,991
+15
| +0.5% | +$8.26K | 0.2% | 67 |
|
|
2022
Q3 | $1.51M | Hold |
2,976
| – | – | 0.19% | 64 |
|
|
2022
Q2 | $1.62M | Sell |
2,976
-20
| -0.7% | -$10.9K | 0.19% | 69 |
|
|
2022
Q1 | $1.77M | Buy |
2,996
+13
| +0.4% | +$7.68K | 0.16% | 76 |
|
|
2021
Q4 | $1.99M | Buy |
2,983
+61
| +2% | +$40.7K | 0.16% | 80 |
|
|
2021
Q3 | $1.67M | Sell |
2,922
-61
| -2% | -$34.8K | 0.15% | 79 |
|
|
2021
Q2 | $1.51M | Buy |
2,983
+548
| +23% | +$276K | 0.14% | 87 |
|
|
2021
Q1 | $1.11M | Sell |
2,435
-168
| -6% | -$76.7K | 0.11% | 112 |
|
|
2020
Q4 | $1.21M | Buy |
2,603
+1,068
| +70% | +$497K | 0.13% | 99 |
|
|
2020
Q3 | $678K | Buy |
1,535
+35
| +2% | +$15.5K | 0.08% | 139 |
|
|
2020
Q2 | $544K | Buy |
+1,500
| New | +$544K | 0.07% | 146 |
|